1. Kohler N, Sun C, Wang J, Zhang M. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Langmuir. 2005;21(19):8858–64.
2. Vechasilp J, Tangtrakulwanich B, Oungbho K, Yuenyongsawad S. The efficacy of methotrexate-impregnated hydroxyapatite composites on human mammary carcinoma cells. J Orthop Surg (Hong Kong). 2007;15(1):56–61.
3. Lünenbürger H, Lanvers-Kaminsky C, Lechtape B, Frühwald MC. Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell lines. Anticancer Drugs. 2010;21(5):514–22.
4. Nakamura T, Nakatsu N, Yoshida Y, Yamazaki K, Dan S, Sadahiro S, et al. Identification of candidate genes determining chemosensitivity to anti-cancer drugs of gastric cancer cell lines. Biol Pharm Bull. 2009;32(11):1936–9.
5. Frei E, Jaffe N, Tattersall MH, Pitman S, Parker L. New approaches to cancer chemotherapy with methotrexate. N Engl J Med. 1975;292(16):846–51.